Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

unknown133%
withdrawn133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

NCT01202851
unknown

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

NCT04782674
withdrawnnot_applicable

Effects of a Group Residential Retreat on Cancer Outcomes

NCT02429544

Clinical Trials (3)

Showing 3 of 3 trials
NCT01202851Phase 3

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

Active Not Recruiting
NCT04782674

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Unknown
NCT02429544Not Applicable

Effects of a Group Residential Retreat on Cancer Outcomes

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3